Publications with Prof. Kim
6. Park, J.W.*, Shin, J.*, Gong, E.Y., Kim, S.Y., Lee, J.A., Jo, M.G., Choi, W.S., Min, K.Y., Choi, Y.H., Kim, S.H.*, Kim, H.S.* Lanatoside C attenuates atopic dermatitis by limiting T-cell infiltration through CCR4 and CCR8 modulation. Experimental and Therapeutic Medicine. 2026 Mar 5; Accepted.
5. Kim, S.Y., Park, J.W., Shin, J., Lee, J.A., Leem, S.H., Jo, M.G., Choi, M.Y., Choi, W.S., Min, K.Y., Noh, G., Bae, S.J., Choi, Y.H., Kim, H.S. Pluviatolide attenuates type I hypersensitivity through regulation of mast cell activation. Biomolecules & Therapeutics. 2026 Mar 1; 34(2):413-422. doi: 10.4062/biomolther.2025.164.
4. Park, J.W.*, Kang, M.*, Kim, G.*, Hyun, S.Y., Shin, J., Kim, S.Y., Lee, J.H., Choi, W.S., Lee, J.H., Lee, K., Kim, S.H., Cho, W.S.*, Kim, H.S.* The impact of atmospheric ultrafine particulate matter on IgE-mediated type 1 hypersensitivity reaction. Journal of Hazardous Materials. 2025 Feb 15;484:136705. doi: 10.1016/j.jhazmat. 2024.136705. (IF 12.2 JCR 2023) Epub 2024 Nov 29.
3. Shin, J.H., Park, J.W., Kim, S.Y., Lee, J.H., Choi, W.S., Kim, H.S. Strategies for Overcoming Immune Evasion in Bladder Cancer. International Journal of Molecular Sciences. 2024 Mar 7;25(6):3105. doi: 10.3390/ijms25063105.
2. Min, K.Y.*, Kim, D.K.*, Jo, M.G., Choi, M.Y., Lee, D., Park, J.W., Park, Y.J., Chung, Y., Kim, Y.M., Park, Y.M., Kim, H.S.*, Choi, W.S.* IL-27-induced PD-L1highSca-1+ innate lymphoid cells suppress contact hypersensitivity in an IL-10-dependent manner. Experimental & Molecular Medicine. 2024 Mar 1; 56(3):616-629. doi: 10.1038/s12276-024-01187-1. (IF 12.8 JCR 2022)
1. Hyun, S.Y.*, Kim, E.Y.*, Kang, M.S., Park, J.W., Hong, K.S., Chung, H.M., Choi, W.S., Park, S.P.*, Noh, G.*, Kim, H.S.* Embryonic‑stem‑cell‑derived mesenchymal stem cells relieve experimental contact urticaria by regulating the functions of mast cells and T cells. Scientific Reports. 2023 Dec 20; 13:22694. doi: 10.1038/s41598-023-50258-2.
Publications with Prof. Kim
4. Park, J.W.*, Shin, J.*, Gong, E.Y., Kim, S.Y., Lee, J.A., Jo, M.G., Choi, W.S., Min, K.Y., Choi, Y.H., Kim, S.H.*, Kim, H.S.* Lanatoside C attenuates atopic dermatitis by limiting T-cell infiltration through CCR4 and CCR8 modulation. Experimental and Therapeutic Medicine. 2026 Mar 5; Accepted.
3. Kim, S.Y., Park, J.W., Shin, J., Lee, J.A., Leem, S.H., Jo, M.G., Choi, M.Y., Choi, W.S., Min, K.Y., Noh, G., Bae, S.J., Choi, Y.H., Kim, H.S. Pluviatolide attenuates type I hypersensitivity through regulation of mast cell activation. Biomolecules & Therapeutics. 2026 Mar 1; 34(2):413-422. doi: 10.4062/biomolther.2025.164.
2. Park, J.W.*, Kang, M.*, Kim, G.*, Hyun, S.Y., Shin, J., Kim, S.Y., Lee, J.H., Choi, W.S., Lee, J.H., Lee, K., Kim, S.H., Cho, W.S.*, Kim, H.S.* The impact of atmospheric ultrafine particulate matter on IgE-mediated type 1 hypersensitivity reaction. Journal of Hazardous Materials. 2025 Feb 15;484:136705. doi: 10.1016/j.jhazmat. 2024.136705. (IF 12.2 JCR 2023) Epub 2024 Nov 29.
1. Shin, J., Park, J.W., Kim, S.Y., Lee, J.H., Choi, W.S., Kim, H.S. Strategies for Overcoming Immune Evasion in Bladder Cancer. International Journal of Molecular Sciences. 2024 Mar 7;25(6):3105. doi: 10.3390/ijms25063105.
Publications with Prof. Kim
2. Park, J.W.*, Shin, J.*, Gong, E.Y., Kim, S.Y., Lee, J.A., Jo, M.G., Choi, W.S., Min, K.Y., Choi, Y.H., Kim, S.H.*, Kim, H.S.* Lanatoside C attenuates atopic dermatitis by limiting T-cell infiltration through CCR4 and CCR8 modulation. Experimental and Therapeutic Medicine. 2026 Mar 5; Accepted.
1. Kim, S.Y., Park, J.W., Shin, J., Lee, J.A., Leem, S.H., Jo, M.G., Choi, M.Y., Choi, W.S., Min, K.Y., Noh, G., Bae, S.J., Choi, Y.H., Kim, H.S. Pluviatolide attenuates type I hypersensitivity through regulation of mast cell activation. Biomolecules & Therapeutics. 2026 Mar 1; 34(2):413-422. doi: 10.4062/biomolther.2025.164.